Biomedical Engineering Reference
In-Depth Information
B) exerts a
negative feedback loop that limits platelet activation [ 168 ]. Factor NF
Nuclear factor-
κ
light chain-enhancer of activated B cells (NF
κ
κ
B builds a
complex with protein kinase-A that contains inhibitor of NF
κ
BI
κ
B
α
. The latter is
phosphorylated by inhibitor of NF
B kinase. This event releases PKA that can then
phosphorylate the actin-dynamics inhibitor vasodilator-stimulated phosphoprotein.
The NF
κ
B-PKA pathway is stimulated by thrombin and collagen. It limits platelet
activation and motility, hence thrombus stability, as it reduces cytoskeletal dynamics
and early-stage aggregation.
Diverse elements of the NF
κ
κ
B family in platelets produce different associations
of NF
B subunits that initiate different signalings according to the source of platelet
stimulation. Fibrinogen-activated platelets cause platelet spreading via NF
κ
κ
Bthat
influences fibrinogen binding to
α 2B β 3 -integrin [ 169 ].
Thrombin-activated platelets, but not resting cells, synthesize B-cell lymphoma-3
protein [ 170 ]. Protein BCL3 is a member of the atypical I
B subfamily that acts not
only as a transcriptional coregulator, but also as a component of the autoregulatory
loop via its association with NF
κ
B. In activated platelets, BCL3 interacts with Fyn
kinase to produce a retracted fibrin clot, the clot consisting of aggregated platelets
and a mesh of fibrins.
Furthermore, inhibitor of NF
κ
κ
B kinases have other substrates than inhibitors
of NF
B, such as AMPK and MAP3K7 kinases [ 171 ]. In platelets, AMPK and
MAP3K7 contribute to signaling for adhesion and aggregation of platelets as well
as exocytosis of mediators.
κ
3.6.6
Other Regulators of the Platelet Function
At least, 3 subtypes of P2 receptors are implicated in platelet activation: P2X 1 ,
P2Y 1 ,andP2Y 12 (Vol. 3 - Chaps. 2. Membrane Ion Carriers and 7. G-Protein-
Coupled Receptors). Ion channel P2X 1 activated by ATP during collagen-induced
platelet activation generates a rapid influx of calcium, which leads to a change
in platelet shape and platelet aggregation. Gq-coupled P2Y 1 receptor also modifies
platelet shape and provokes aggregation via calcium influx. Adenosine diphos-
phate binds to the P2Y 1 receptor. Gi-coupled P2Y 12 receptor that binds ADP
inhibits adenylate cyclase. The activation of phosphatidylinositol 3-kinase by ADP
G-protein-coupled receptors triggers platelet aggregation.
The Wnt-
-catenin signaling pathway functions in human platelets [ 172 ].
Platelets possess Wnt receptors such as Frizzled-4 and -6 receptors as well as LRP5
and LRP6 coreceptors and Disheveled-2 mediator. Wnt3a ligand prevents platelet
activation, dense granule secretion, adhesion, and aggregation [ 172 ]. In addition,
Wnt3a hampers the thrombin-induced activation of RhoA GTPase (non-canonical
Wnt signaling). Among non-genomic functions,
β
β
-catenins link adhesion receptors
of the cadherin family to the actin cytoskeleton.
Search WWH ::




Custom Search